FinZonalExplore Data →
← CompaniesCOMPANY FINANCIAL PROFILE

NOVO NORDISK A S

NVO · CIK 0000353278 · Pharmaceutical Preparations

Last SEC sync: Nov 7, 2026 18:25 UTC

About NOVO NORDISK A S

A verified business description has not yet been added. Explore the SEC filings and financial statements below for primary-source information.

Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.

Financial highlights

Latest qualifying annual SEC observations · USD
Revenue—Not available
Net Income—Not available
Operating Income—Not available
Total Assets—Not available
Total Liabilities—Not available
Cash and Cash Equivalents—Not available
Operating Cash Flow—Not available
Revenue growth · latest comparable annual periods—
Net profit margin · matching fiscal period—

Historical financial performance

USD billions · Annual SEC observations · Choose a metric

Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.

Annual financial history

USD · Exact fiscal period ends
Period endedRevenueNet incomeOperating incomeAssetsLiabilitiesCashOperating cash flowNet margin
No qualifying annual financial data available.

A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.

Company information

Registered name
NOVO NORDISK A S
Ticker symbol
NVO
CIK
0000353278
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC SIC code
2834
Fiscal year end (MMDD)
1231
Last SEC synchronization
Nov 7, 2026 18:25 UTC
Headquarters / business address
NOVO ALLE DK 2880
BAGSVAERD DENMARK, G7 00000
Mailing address
NOVO ALLE DK 2880
BAGSVAERD DENMARK, G7 00000
Business phone
4544448888

Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 7, 2026 20:23 UTC. Official website, business descriptions and executive details require separate verification.

Latest SEC filings

Browse filings →
FormFiledReport periodOfficial source
6-KNov. 5, 2026Nov. 5, 2026View SEC filing ↗
6-KNov. 4, 2026Sept. 30, 2026View SEC filing ↗
6-KNov. 3, 2026Nov. 3, 2026View SEC filing ↗
6-KOct. 26, 2026Oct. 26, 2026View SEC filing ↗
6-KOct. 19, 2026Oct. 19, 2026View SEC filing ↗
6-KOct. 13, 2026Oct. 12, 2023View SEC filing ↗
6-KOct. 6, 2026Oct. 5, 2026View SEC filing ↗
6-KOct. 5, 2026Oct. 2, 2026View SEC filing ↗
6-KSept. 28, 2026Sept. 28, 2026View SEC filing ↗
6-KSept. 21, 2026Sept. 21, 2026View SEC filing ↗
6-KSept. 17, 2026Sept. 17, 2026View SEC filing ↗
6-KSept. 15, 2026Sept. 14, 2026View SEC filing ↗
6-KSept. 9, 2026Sept. 7, 2026View SEC filing ↗
6-KAug. 31, 2026Aug. 31, 2026View SEC filing ↗
6-KAug. 24, 2026Aug. 24, 2026View SEC filing ↗
6-KAug. 18, 2026Aug. 17, 2026View SEC filing ↗
6-KAug. 10, 2026Aug. 6, 2026View SEC filing ↗
6-KAug. 10, 2026Aug. 10, 2026View SEC filing ↗
6-KAug. 4, 2026Aug. 4, 2026View SEC filing ↗
6-KAug. 4, 2026Aug. 4, 2026View SEC filing ↗

Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.